Track this topic across federal Congress bills, then open each bill page for full context and activity.
| Bill | Title | Congress | Status | Action Date |
|---|---|---|---|---|
| HR 5982 |
Safe Medicine Act
|
116th | Referred to the House Committee on Energy and Commerce. | February 26, 2020 |
| HR 5966 |
Restore and Modernize Our National Labs Act
|
116th | Referred to the House Committee on Science, Space, and Technology. | February 25, 2020 |
| HR 5927 |
Safe Medicine Act
|
116th | Referred to the House Committee on Energy and Commerce. | February 18, 2020 |
| HR 5894 |
Transparency in Prescription Drug Advertising Act
|
116th | Referred to the House Committee on Energy and Commerce. | February 13, 2020 |
| HR 5882 |
GENE Therapy Payment Act
|
116th | Referred to the House Committee on Energy and Commerce. | February 12, 2020 |
| HR 5774 |
Veterans HOPE Act
|
116th | Referred to the Subcommittee on Health. | March 2, 2020 |
| HR 5668 |
MODERN Labeling Act of 2020
|
116th | Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. | November 18, 2020 |
| HR 5663 |
Safeguarding Therapeutics Act
|
116th | Became Public Law No: 116-304. | January 5, 2021 |
| HR 5632 |
FDA Accountability for Public Safety Act
|
116th | Referred to the House Committee on Energy and Commerce. | January 16, 2020 |
| HR 5587 |
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived can...
|
116th | Referred to the Subcommittee on Biotechnology, Horticulture, and Research. | January 23, 2020 |
| HR 5578 |
Recall Unsafe Drugs Act of 2020
|
116th | Referred to the House Committee on Energy and Commerce. | January 10, 2020 |
| HR 5501 |
Affordable Drug Manufacturing Act of 2019
|
116th | Referred to the Subcommittee on Health. | December 20, 2019 |
| HR 5497 |
Conditional Approval Act
|
116th | Referred to the Subcommittee on Health. | December 20, 2019 |
| HR 5482 |
PREVENT Act of 2020
|
116th | Referred to the Subcommittee on Health. | December 19, 2019 |
| HR 5480 |
ALS Placebo No More Act
|
116th | Referred to the Subcommittee on Health. | December 19, 2019 |
| HR 5444 |
Lower Insulin Costs Now Act
|
116th | Referred to the Subcommittee on Health. | December 18, 2019 |
| HR 5402 |
Protecting America’s Life Saving Medicines Act of 2019
|
116th | Referred to the Subcommittee on Health. | December 12, 2019 |
| HR 5400 |
National Biomedical Research Act
|
116th | Referred to the Subcommittee on Health. | December 12, 2019 |
| HR 5381 |
International Pharmaceutical Transparency Act of 2019
|
116th | Referred to the Subcommittee on Health. | December 11, 2019 |
| HR 5333 |
Ensuring Patient Access to Critical Breakthrough Products Act of 2019
|
116th | Referred to the Subcommittee on Health. | December 9, 2019 |
| HR 5279 |
Cosmetic Safety Enhancement Act of 2019
|
116th | Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote . | March 11, 2020 |
| HR 5216 |
Quality Care for Nursing Home Residents Act of 2019
|
116th | Referred to the Subcommittee on Health. | November 22, 2019 |
| HR 5198 |
Patients’ Right to Know Their Medication Act of 2019
|
116th | Referred to the Subcommittee on Health. | November 21, 2019 |
| HR 5141 |
Humane Cosmetics Act of 2019
|
116th | Referred to the Subcommittee on Health. | November 19, 2019 |
| HR 5133 |
Affordable Prescriptions for Patients Through Promoting Competition Act of 2019
|
116th | Placed on the Union Calendar, Calendar No. 578. | December 24, 2020 |
| HR 5031 |
Medical Innovation Act of 2019
|
116th | Referred to the Subcommittee on Health. | November 12, 2019 |
| HR 4974 |
MATE Act of 2019
|
116th | Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. | December 18, 2019 |
| HR 4955 |
Protecting Access to Safe and Effective Medicines Act of 2019
|
116th | Referred to the Subcommittee on Health. | November 1, 2019 |
| HR 4906 |
Insulin Price Reduction Act
|
116th | Referred to the Subcommittee on Health. | October 30, 2019 |
| HR 4866 |
National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020
|
116th | Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. | September 22, 2020 |
| HR 4742 |
Protecting American Lungs Act of 2019
|
116th | Placed on the Union Calendar, Calendar No. 322. | February 21, 2020 |
| HR 4712 |
Fairness in Orphan Drug Exclusivity Act
|
116th | Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. | November 18, 2020 |
| HR 4710 |
Pharmaceutical Independence Long-Term Readiness Reform Act
|
116th | Referred to the Subcommittee on Health. | November 8, 2019 |
| HR 4667 |
Biomedical Innovation Expansion Act of 2019
|
116th | Referred to the Subcommittee on Health. | October 14, 2019 |
| HR 4640 |
Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2019
|
116th | Referred to the Subcommittee on Health. | October 14, 2019 |
| HR 4633 |
Investing in Safety and Innovation Act of 2019
|
116th | Referred to the Subcommittee on Health. | October 14, 2019 |
| HR 4624 |
END ENDS Act of 2019
|
116th | Referred to the Subcommittee on Health. | October 9, 2019 |
| HR 4553 |
Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act
|
116th | Referred to the Subcommittee on Health. | September 30, 2019 |
| HR 4460 |
Turn the Tide Act
|
116th | Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. | October 28, 2019 |
| HR 4439 |
Creating Hope Reauthorization Act
|
116th | Received in the Senate. | September 30, 2020 |